Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Nov 2026, 17:12:52 UTC
Prior SEC filing
30 Oct 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Venrock Healthcare Capital Partners III, L.P., By: VHCP Management III, LLC, Its: General Partner, By: /s/ Sherman G. Souther, Authorized Signatory
Filing notes and source

Key filing fact

Venrock Healthcare Capital Partners III, L.P. filed Form 4 for Lycia Therapeutics, Inc. (LYCA) on 04 Nov 2026.

Key facts

  • This page summarizes Venrock Healthcare Capital Partners III, L.P.'s Form 4 filing for Lycia Therapeutics, Inc. (LYCA).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 04 Nov 2026, 17:12.

Change

  • Previous filing in this sequence was filed on 30 Oct 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (9)

CIK 0001738048 Primary reporting owner

Venrock Healthcare Capital Partners III, L.P.

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
Venrock Healthcare Capital Partners III, L.P., By: VHCP Management III, LLC, Its: General Partner, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
04 Nov 2026
CIK 0001750761

VHCP Co-Investment Holdings III, LLC

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
VHCP Co-Investment Holdings III, LLC, By: VHCP Management III, LLC, Its: Manager, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
04 Nov 2026
CIK 0001738053

VHCP Management III, LLC

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
VHCP Management III, LLC, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
04 Nov 2026
CIK 0001808512

Venrock Healthcare Capital Partners EG, L.P.

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
Venrock Healthcare Capital Partners EG, L.P., By: VHCP Management EG, LLC, Its: General Partner, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
04 Nov 2026
CIK 0001808518

VHCP Management EG, LLC

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
VHCP Management EG, LLC, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
04 Nov 2026
CIK 0002037157

Venrock Healthcare Capital Partners XP, L.P.

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
Venrock Healthcare Capital Partners XP, L.P., By: VHCP Management XP, LLC, Its: General Partner, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
04 Nov 2026
CIK 0002037104

VHCP Management XP, LLC

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
VHCP Management XP, LLC, By: /s/ Sherman G. Souther, Authorized Signatory
Signature date
04 Nov 2026
CIK 0001615979

Koh Bong Y

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
Bong Y. Koh, By: /s/ Sherman G. Souther, Attorney-in-Fact
Signature date
04 Nov 2026
CIK 0001698082

Shah Nimish P

Relationship
10%+ Owner
Address
C/O VENROCK, 7 BRYANT PARK, 23RD FLOOR, NEW YORK
Signature
Nimish P. Shah, By: /s/ Sherman G. Souther, Attorney-in-Fact
Signature date
04 Nov 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LYCA transaction

Common Stock

Purchase

Transaction value
Shares
+8,305
Change %
+0.12%
Price
$26.95*
Shares after
6,858,542
Date
02 Nov 2026
Ownership
By Funds
Footnotes
F1, F2, F3, F4, F5, F6
LYCA transaction

Common Stock

Purchase

Transaction value
Shares
+8,305
Change %
+0.12%
Price
$26.95*
Shares after
6,858,542
Date
02 Nov 2026
Ownership
By Funds
Footnotes
F1, F2, F3, F4, F5, F6
LYCA transaction

Common Stock

Purchase

Transaction value
Shares
+8,305
Change %
+0.12%
Price
$26.95*
Shares after
6,858,542
Date
02 Nov 2026
Ownership
By Funds
Footnotes
F1, F2, F3, F4, F5, F6
LYCA transaction

Common Stock

Purchase

Transaction value
Shares
+8,305
Change %
+0.12%
Price
$26.95*
Shares after
6,858,542
Date
02 Nov 2026
Ownership
By Funds
Footnotes
F1, F2, F3, F4, F5, F6
LYCA transaction

Common Stock

Purchase

Transaction value
Shares
+8,305
Change %
+0.12%
Price
$26.95*
Shares after
6,858,542
Date
02 Nov 2026
Ownership
By Funds
Footnotes
F1, F2, F3, F4, F5, F6
LYCA transaction

Common Stock

Purchase

Transaction value
Shares
+8,305
Change %
+0.12%
Price
$26.95*
Shares after
6,858,542
Date
02 Nov 2026
Ownership
By Funds
Footnotes
F1, F2, F3, F4, F5, F6
LYCA transaction

Common Stock

Purchase

Transaction value
Shares
+8,305
Change %
+0.12%
Price
$26.95*
Shares after
6,858,542
Date
02 Nov 2026
Ownership
By Funds
Footnotes
F1, F2, F3, F4, F5, F6
LYCA transaction

Common Stock

Purchase

Transaction value
Shares
+8,305
Change %
+0.12%
Price
$26.95*
Shares after
6,858,542
Date
02 Nov 2026
Ownership
By Funds
Footnotes
F1, F2, F3, F4, F5, F6
LYCA transaction

Common Stock

Purchase

Transaction value
Shares
+8,305
Change %
+0.12%
Price
$26.95*
Shares after
6,858,542
Date
02 Nov 2026
Ownership
By Funds
Footnotes
F1, F2, F3, F4, F5, F6
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

Consists of (i) 3,775 shares held by Venrock Healthcare Capital Partners III, L.P. ("VHCP3"); (ii) 378 shares held by VHCP Co-Investment Holdings III,LLC ("VHCP Co-3"); and (iii) 4,152 shares held by Venrock Healthcare Capital Partners EG, L.P. ("VHCP EG").

Footnote F2

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions at prices ranging from $26.60 to $27.00 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.

Footnote F3

Consists of (i) 1,773,271 shares held by VHCP3; (ii) 177,470 shares held by VHCP Co-3; (iii) 4,256,011 shares held by VHCP EG; and (iv) 651,790 shares held by Venrock Healthcare Capital Partners XP, L.P. ("VHCP XP").

Footnote F4

VHCP Management III, LLC ("VHCPM3") is the general partner of VHCP3 and the manager of VHCP Co-3 and may be deemed to beneficially own the shares held by VHCP3 and VHCP Co-3. Bong Koh and Nimish Shah are the voting members of VHCPM3 and may be deemed to beneficially own these shares. Each of VHCPM3 and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.

Footnote F5

VHCP Management EG, LLC ("VHCPMEG") is the general partner of VHCP EG and may be deemed to beneficially own the shares held by VHCP EG. Bong Koh and Nimish Shah are the voting members of VHCPMEG and may be deemed to beneficially own these shares. Each of VHCPMEG and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.

Footnote F6

VHCP Management XP, LLC ("VHCPMXP") is the general partner of VHCP XP and may be deemed to beneficially own the shares held by VHCP XP. Bong Koh and Nimish Shah are the voting members of VHCPMXP and may be deemed to beneficially own these shares. Each of VHCPMXP and Messrs. Koh and Shah expressly disclaims beneficial ownership over these shares except to the extent of its or his indirect pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .